SPRY – ars pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results [Yahoo! Finance]
ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization Application to EMA’s CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy in Australia and New Zealand
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
Form 8-K ARS Pharmaceuticals, For: May 10
Form 4 ARS Pharmaceuticals, For: May 07 Filed by: Tanimoto Sarina
Form 4 ARS Pharmaceuticals, For: May 07 Filed by: Lowenthal Richard E
Form 10-Q ARS Pharmaceuticals, For: Mar 31
Form 8-K ARS Pharmaceuticals, For: May 09
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.